Rankings
▼
Calendar
XENE FY 2022 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
XENE
Xenon Pharmaceuticals Inc.
$5B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
-48.8% YoY
Gross Profit
$9M
100.0% margin
Operating Income
-$129M
-1368.9% margin
Net Income
-$125M
-1328.9% margin
EPS (Diluted)
$-2.06
Cash Flow
Operating Cash Flow
-$98M
Free Cash Flow
-$101M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$754M
Total Liabilities
$33M
Stockholders' Equity
$721M
Cash & Equivalents
$57M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$18M
-48.8%
Gross Profit
$9M
$18M
-48.8%
Operating Income
-$129M
-$79M
-63.5%
Net Income
-$125M
-$79M
-58.9%
← Q4 2021
All Quarters
Q1 2022 →